Knowledge Resource Center for Ecological Environment in Arid Area
DOI | 10.7150/thno.52717 |
m(6)A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer | |
Chong, Wei; Shang, Liang; Liu, Jin; Fang, Zhen; Du, Fengying; Wu, Hao; Liu, Yang; Wang, Zhe; Chen, Yang; Jia, Shengtao; Chen, Liming; Li, Leping; Chen, Hao | |
通讯作者 | Li, LP (corresponding author), Shandong First Med Univ, Shandong Prov Hosp, Dept Gastrointestinal Surg, Jinan 250021, Shandong, Peoples R China. ; Chen, H (corresponding author), Shandong Univ, Qilu Hosp, Clin Res Ctr, Clin Epidemiol Unit, Jinan 250021, Shandong, Peoples R China. |
来源期刊 | THERANOSTICS |
ISSN | 1838-7640 |
出版年 | 2021 |
卷号 | 11期号:5页码:2201-2217 |
英文摘要 | Recent studies have highlighted the biological significance of RNA N-6-methyladenosine (m(6)A) modification in tumorigenicity and progression. However, it remains unclear whether m(6)A modifications also have potential roles in immune regulation and tumor microenvironment (TME) formation. Methods: In this study, we curated 23 m(6)A regulators and performed consensus molecular subtyping with NMF algorithm to determine m(6)A modification patterns and the m(6)A-related gene signature in colon cancer (CC). The ssGSEA and CIBERSORT algorithms were employed to quantify the relative infiltration levels of various immune cell subsets. An PCA algorithm based m(6)Sig scoring scheme was used to evaluate the m(6)A modification patterns of individual tumors with an immune response. Results: Three distinct m(6)A modification patterns were identified among 1307 CC samples, which were also associated with different clinical outcomes and biological pathways. The TME characterization revealed that the identified m(6)A patterns were highly consistent with three known immune profiles: immune-inflamed, immune-excluded, and immune-desert, respectively. Based on the m(6)Sig score, which was extracted from the m(6)A-related signature genes, CC patients can be divided into high and low score subgroups. Patients with lower m(6)Sig score was characterized by prolonged survival time and enhanced immune infiltration. Further analysis indicated that lower m(6)Sig score also correlated with greater tumor mutation loads, PD-L1 expression, and higher mutation rates in SMGs (e.g., PIK3CA and SMAD4). In addition, patients with lower m(6)Sig scores showed a better immune responses and durable clinical benefits in three independent immunotherapy cohorts. Conclusions: This study highlights that m(6)A modification is significantly associated with TME diversity and complexity. Quantitatively evaluating the m(6)A modification patterns of individual tumors will strengthen our understanding of TME characteristics and promote more effective immunotherapy strategies. |
英文关键词 | Colon cancer m(6)A modification Tumor microenvironment Immune profiles Immunotherapy |
类型 | Article |
语种 | 英语 |
开放获取类型 | gold, Green Published |
收录类别 | SCI-E |
WOS记录号 | WOS:000600556000015 |
WOS关键词 | COLORECTAL-CANCER ; CHECKPOINT BLOCKADE ; IMMUNOPHENOTYPE ; SIGNATURE ; HALLMARKS ; CELLS |
WOS类目 | Medicine, Research & Experimental |
WOS研究方向 | Research & Experimental Medicine |
资源类型 | 期刊论文 |
条目标识符 | http://119.78.100.177/qdio/handle/2XILL650/348249 |
作者单位 | [Chong, Wei; Shang, Liang; Li, Leping] Shandong First Med Univ, Shandong Prov Hosp, Dept Gastrointestinal Surg, Jinan 250021, Shandong, Peoples R China; [Chong, Wei; Shang, Liang; Fang, Zhen; Du, Fengying; Wu, Hao; Liu, Yang; Li, Leping] Shandong Univ, Shandong Prov Hosp, Cheeloo Coll Med, Dept Gastrointestinal Surg, Jinan 250021, Shandong, Peoples R China; [Chong, Wei; Shang, Liang; Fang, Zhen; Du, Fengying; Wu, Hao; Liu, Yang; Li, Leping] Shandong Prov Hosp, Key Lab Engn Shandong Prov, Jinan 250021, Shandong, Peoples R China; [Liu, Jin] Shandong Prov Hosp, Dept Gastroenterol, Key Lab Engn Shandong Prov, Jinan 250021, Shandong, Peoples R China; [Wang, Zhe] Tianjin Sino US Diagnost Co Ltd, Tianjin, Peoples R China; [Chen, Yang] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Radiat Oncol, Tianjin, Peoples R China; [Chen, Yang] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Chen, Yang] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China; [Jia, Shengtao] Tianjin Med Univ Canc In... |
推荐引用方式 GB/T 7714 | Chong, Wei,Shang, Liang,Liu, Jin,et al. m(6)A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer[J],2021,11(5):2201-2217. |
APA | Chong, Wei.,Shang, Liang.,Liu, Jin.,Fang, Zhen.,Du, Fengying.,...&Chen, Hao.(2021).m(6)A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer.THERANOSTICS,11(5),2201-2217. |
MLA | Chong, Wei,et al."m(6)A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer".THERANOSTICS 11.5(2021):2201-2217. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。